Tomorrow at President Biden’s first G-7 meeting as commander-in-chief, an announcement will be made by the White Hourse outlining $4 billion in funding that will provide Covid vaccines to 92 low-and-middle income countries. Thus far, Covid vaccines have been made readily available to rich nations while poorer nations have previously been relegated to months-long delays. Now, with this infusion of money through a multilateral agreement, that wait will be substantially decreased.
Biden will use the G-7 to rally support and additional funding from fellow leaders. $2 billion of the funding will be released right away to GAVI, the Vaccine Alliance with the remaining $2 billion depersed over the course of two years with the caveat that other rich countries make good on their pledges. The United States reentry in the global health community especially the World Health Organization is a stanch repudiation of Trump’s withdrawal from the world health’s governing body.
Continue reading Biden Agrees to $4 Billion in Funding for Global Equitable Access to COvid Vaccines
As is true with each new presidential administration the global health community hangs in the balance. According to KFF.org the US global health funding was set at $11 billion in FY 2019 and in 2020 the funding was significantly decreased. This funding goes towards programs in more than 70 countries for HIV, malaria, maternal and child health among other health challenges. But now with the Biden administration the global health imperative is back on the table with increased funding and a dedication to countries’ health. Here are four reasons why.
- At the start of the last administration the lamentations were heard around the world about the reinstatement of the Mexico City Policy or the Global Gage Rule, that cut overseas funding from advocating for the legalization of abortions, provide abortions, mention the word, or even refer women to health practionioners that provide safe, legal abortions. Biden has already revoked the Mexico City Policy, but according to Time magazine the Trump effect may take some time to undo.
- The Trump administration also withdrew from the World Health Organization (WHO), something that seemed unfathomable, but was a stark wakeup call for the global health community. Biden stopped the United States’ official withdrawal from the WHO. This is important as the US provides significant funding for global health and by re-entering the worldwide health community, the US will help stabilize the global COVID-19 response.
- Not only did the Trump administration withdraw from the World Health Organization, it also withdrew from The Paris Climate Agreement signed in 2015. Make no mistake, while the Agreement sets conditions and milestones for countries to reach to stave off and prevent further climate extremes it is very much a health agreement. Again, Biden rejoined The Paris Agreement, putting the United States back on a solid footing on climate change initiatives.
- Biden’s nominee for administrator of USAID is Samantha Power. With years of global health and administration experience under her belt, Power is the former US ambassador to the United Nations under Obama. Additionally, Power served as Special Assistant to the President and Senior Director for Multilateral Affairs and Human Rights at the National Security Council. Power will certainly raise the profile of USAID and usher a renewed sense of the United States’ responsibility to global health and security.
In the first few weeks of Biden’s administration there have been several notable changes in how the United States approaches global health. This is especially imperative with the COVID-19 pandemic still raging out of control with new variants and a backed-up vaccine rollout. Now, there is a plan in place not only for the United States, but also for global distribution of the vaccine where the vast majority of the vaccines have gone to high-income countries according to Duke Univeristy’s Global Health Instutute.
It is no surprise that the world needs more health workers. In fact, even though there are currently 22 million nurses and 2 million midwives globally there is an urgent need for 18 million more health workers in order to reach universal health care coverage by 2030 according to the World Health Organization.
There is a particular need for 9 million nurses and midwives as they are critical components to a robust health system and are often on the front lines of general and critical care including:
Continue reading 2020 Marks The International Year of The Nurse and The Midwife #SupportNursesAndMidwives
- Prevention, diagnosis, and treatment of HIV, tuberculosis, malaria and other communicable diseases
- Prevention, diagnosis and treatment of noncommunicable diseases
- Sexual and reproductive health services, including family planning, and maternal and newborn health care, including immunization and breastfeeding support.
As I have written many times before postpartum hemorrhage (PPH) or excessive uterine bleeding after childbirth is the leading cause of maternal mortality in low-and-middle income countries. The recommended drug to prevent PPH according to the World Health Organization (WHO) is oxytocin. When administered in its recommended dose it causes little to no side effects. Oxytocin, the WHO’s current gold standard therapy, however, must be refrigerated and administered by skilled health workers posing two obstacles to its wider use in low resource, tropical settings.
Some countries have approved misoprostol, an oral drug, to prevent PPH, but there are several concerns that its use can be misappropriated for abortions instead of used solely for PPH. The World Health Organization has listed misoprostol as an alternative to oxytocin if it is not available.
Now, another PPH preventative drug, carbetocin, has been added to the latest updated 2019 WHO Essential Medicines List. The announcement was made last week. Unlike oxytocin, even at high temperatures carbetocin remains effective. The recommendation is that carbetocin can be used when oxytocin is not available or if its quality is uncertain. Additionally, the cost must be comparable to oxytocin.
Continue reading NEW: Drug That Prevents PostPartum Hemorrhage Added To WHO Essential Medicines List
Yesterday global women’s and children’s advocates sounded the alarm regarding alleged strong-arming by US delegates at this year’s World Health Assembly (WHA) in Geneva. The issue at hand was the rights of women regarding their choice between breastfeeding and formula feeding.
According to the New York Times, the US delegation sought to remove the language in a pro-breastfeeding resolution that compelled countries to “protect, promote and support breastfeeding” and to remove any restrictions on formula that many global health experts contend is harmful to infants and toddlers.
The US delegation threatened Ecuador (the sponsoring country for the resolution) with devasting trade measures and a reduction in military aid. Ecuador acquiesced as did many more African and Latin American countries until Russia stepped up to sponsor the resolution, a country the US could not threaten.
Lucy M. Sullivan, Executive Director of 1000 Days, tweeted an entire thread about what was happening at the World Health Assembly in May.
Continue reading Is the Formula Industry Overpowering Breastfeeding?